Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-041060

Chief Medical Officer gave up 5,407 shares (to pay taxes)

  • Chief Medical Officer acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Cawkwell Gail Chief Medical Officer 2023-07-01 Option exercise +15,000 15,000 D
Cawkwell Gail Chief Medical Officer 2023-07-01 Shares withheld for taxes −5,407 $10.37 $56,071 9,593 D
Derivatives
Cawkwell Gail Chief Medical Officer 2023-07-01 Option exercise · Restricted Stock Units −15,000 45,000 D
Loading xslF345X04/doc4.xml…